BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20228030)

  • 1. [Role of T-regulatory cells in multiple sclerosis].
    Rojas JI; González SJ; Patrucco L; Cristiano E
    Medicina (B Aires); 2010; 70(1):79-86. PubMed ID: 20228030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of regulatory T cells in multiple sclerosis.
    Zozulya AL; Wiendl H
    Nat Clin Pract Neurol; 2008 Jul; 4(7):384-98. PubMed ID: 18578001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients.
    Feger U; Luther C; Poeschel S; Melms A; Tolosa E; Wiendl H
    Clin Exp Immunol; 2007 Mar; 147(3):412-8. PubMed ID: 17302889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroinflammation in multiple sclerosis: evidence for autoimmune dysregulation, not simple autoimmune reaction.
    Grigoriadis N; Grigoriadis S; Polyzoidou E; Milonas I; Karussis D
    Clin Neurol Neurosurg; 2006 Mar; 108(3):241-4. PubMed ID: 16388896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immune tolerance and control of CNS autoimmunity: from animal models to MS patients].
    Liblau R; Cassan C
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S12-22. PubMed ID: 18087225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.
    Zozulya AL; Wiendl H
    Hum Immunol; 2008 Nov; 69(11):797-804. PubMed ID: 18723060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune tolerance and control of CNS autoimmunity: from animal models to MS patients.
    Cassan C; Liblau RS
    J Neurochem; 2007 Feb; 100(4):883-92. PubMed ID: 17181557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfunction of IL-10-producing type 1 regulatory T cells and CD4(+)CD25(+) regulatory T cells in a mimic model of human multiple sclerosis in Cynomolgus monkeys.
    Ma A; Xiong Z; Hu Y; Qi S; Song L; Dun H; Zhang L; Lou D; Yang P; Zhao Z; Wang X; Zhang D; Daloze P; Chen H
    Int Immunopharmacol; 2009 May; 9(5):599-608. PubMed ID: 19539557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
    Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
    J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
    Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H
    Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis.
    Kumar M; Putzki N; Limmroth V; Remus R; Lindemann M; Knop D; Mueller N; Hardt C; Kreuzfelder E; Grosse-Wilde H
    J Neuroimmunol; 2006 Nov; 180(1-2):178-84. PubMed ID: 17011048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological basis for the development of tissue inflammation and organ-specific autoimmunity in animal models of multiple sclerosis.
    Korn T; Mitsdoerffer M; Kuchroo VK
    Results Probl Cell Differ; 2010; 51():43-74. PubMed ID: 19513635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered miRNA expression in T regulatory cells in course of multiple sclerosis.
    De Santis G; Ferracin M; Biondani A; Caniatti L; Rosaria Tola M; Castellazzi M; Zagatti B; Battistini L; Borsellino G; Fainardi E; Gavioli R; Negrini M; Furlan R; Granieri E
    J Neuroimmunol; 2010 Sep; 226(1-2):165-71. PubMed ID: 20637509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cells in multiple sclerosis.
    Severson C; Hafler DA
    Results Probl Cell Differ; 2010; 51():75-98. PubMed ID: 19582415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disturbed regulatory T cell homeostasis in multiple sclerosis.
    Venken K; Hellings N; Liblau R; Stinissen P
    Trends Mol Med; 2010 Feb; 16(2):58-68. PubMed ID: 20159585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T cells in the central nervous system.
    Lowther DE; Hafler DA
    Immunol Rev; 2012 Jul; 248(1):156-69. PubMed ID: 22725960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms regulating the development and function of natural regulatory T cells.
    Gupta S; Shang W; Sun Z
    Arch Immunol Ther Exp (Warsz); 2008; 56(2):85-102. PubMed ID: 18373240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.
    Venken K; Hellings N; Hensen K; Rummens JL; Medaer R; D'hooghe MB; Dubois B; Raus J; Stinissen P
    J Neurosci Res; 2006 Jun; 83(8):1432-46. PubMed ID: 16583400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8+ T cells in inflammatory demyelinating disease.
    Weiss HA; Millward JM; Owens T
    J Neuroimmunol; 2007 Nov; 191(1-2):79-85. PubMed ID: 17920696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory T-cell as orchestra leader in immunosuppression process of multiple sclerosis.
    Jadidi-Niaragh F; Mirshafiey A
    Immunopharmacol Immunotoxicol; 2011 Sep; 33(3):545-67. PubMed ID: 21284556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.